FDA approves topical roflumilast for psoriasis in children aged 6-11October 6, 2023PsoriasisPediatricsPsoriatic Arthritis
FDA approves ninth Humira biosimilar, with interchangeabilityOctober 6, 2023Psoriatic ArthritisPediatrics
Severe psoriasis linked to a higher risk for heart disease, study confirmsSeptember 21, 2023PsoriasisPsoriatic Arthritis
Medicare announces 10 drugs targeted for price cuts in 2026August 30, 2023PsoriasisBusiness of MedicinePsoriatic Arthritis
Structural changes may separate axial psoriatic arthritis from axial spondyloarthritisAugust 22, 2023Psoriatic Arthritis
Study validates use of new psoriatic arthritis prediction toolAugust 11, 2023PsoriasisPsoriatic Arthritis
Could risk stratifying methotrexate users lead to less frequent testing?July 28, 2023Psoriatic ArthritisPsoriasis
Keep depression, anxiety screening top of mind in patients with psoriatic diseaseJuly 18, 2023Psoriatic ArthritisPsoriasis
